|
Market Closed -
Hong Kong S.E.
12:08:08 12/08/2026 +04
|
5-day change | 1st Jan Change | ||
| 17.62 HKD | -0.96% |
|
+4.69% | -27.13% |
| 06-25 | 3Sbio Inc. Declares a Final Dividend for the Year Ended 31 December 2025 | CI |
| 05-29 | Innovent Biologics, Pfizer strike $10.5 bln cancer drug deal amid China biotech boom | RE |
| Market Cap | 37.74B 43.91B 5.6B 4.85B 4.54B 4.14B 7.79B 534B 7.91B 53.43B 20.88B 267B 21.01B 20.55B 891B | P/E 2026 * |
14.4x | P/E 2027 * | 14.3x |
|---|---|---|---|---|---|
| Enterprise Value | 25.11B 29.21B 3.72B 3.23B 3.02B 2.76B 5.18B 355B 5.26B 35.54B 13.89B 178B 13.98B 13.67B 593B | EV / Sales 2026 * |
2.48x | EV / Sales 2027 * | 2.25x |
| Free-Float |
74.94% | Yield 2026 * |
1.58% | Yield 2027 * | 1.71% |
| 1 day | -0.96% | ||
| 1 week | +4.69% | ||
| Current month | +5.38% | ||
| 1 month | -2.49% | ||
| 3 months | -18.58% | ||
| 6 months | -26.95% | ||
| Current year | -27.13% |
| 1 week | 17.02 | 18.96 | |
| 1 month | 15.61 | 19.13 | |
| Current year | 14.81 | 29.3 | |
| 1 year | 14.81 | 36.8 | |
| 3 years | 4.91 | 36.8 | |
| 5 years | 4.72 | 36.8 | |
| 10 years | 4.72 | 36.8 |
| Manager | Title | Age | Since |
|---|---|---|---|
Jing Lou
CEO | Chief Executive Officer | 63 | 01/01/2006 |
Xiang He
DFI | Director of Finance/CFO | 43 | 03/07/2023 |
Dong Mei Su
PRN | Corporate Officer/Principal | 56 | 27/11/2014 |
| Director | Title | Age | Since |
|---|---|---|---|
Jing Lou
CHM | Chairman | 63 | 03/04/2012 |
Dong Mei Su
BRD | Director/Board Member | 56 | 11/06/2012 |
Tian Ruo Pu
BRD | Director/Board Member | 57 | 01/06/2015 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 29/07/25 | Other | Chief Executive Officer | 440,000 | 0.0184% | ||
| 15/04/25 | Other | Director | 26,000 | 0.0011% | ||
| 11/04/25 | Other | Director | 460,000 | 0.0192% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -0.96% | +4.69% | -42.19% | +151.00% | 5.65B | ||
| +0.12% | +3.83% | +43.38% | -1.29% | 79.58B | ||
| -3.73% | +4.95% | -2.38% | +25.77% | 52.73B | ||
| -1.95% | -0.67% | +18.86% | +170.42% | 49.77B | ||
| +0.08% | +7.46% | -47.52% | -47.97% | 46.77B | ||
| +2.44% | +1.08% | +62.00% | -23.42% | 30.13B | ||
| -0.25% | +0.81% | +47.98% | +85.12% | 24.54B | ||
| +5.12% | +13.18% | +148.13% | -36.33% | 24.18B | ||
| 0.00% | +10.21% | +6.23% | +188.24% | 21.2B | ||
| +0.17% | +2.26% | +70.79% | +165.74% | 16.36B | ||
| Average | +0.12% | +3.81% | +30.53% | +67.73% | 35.09B | |
| Weighted average by Cap. | -0.25% | +3.67% | +27.71% | +44.33% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 10.11B 11.76B 1.5B 1.3B 1.22B 1.11B 2.09B 143B 2.12B 14.31B 5.59B 71.57B 5.63B 5.5B 239B | 10.43B 12.14B 1.55B 1.34B 1.26B 1.15B 2.15B 148B 2.19B 14.77B 5.77B 73.88B 5.81B 5.68B 246B |
| Net income | 2.68B 3.11B 397M 344M 322M 294M 552M 37.84B 561M 3.79B 1.48B 18.95B 1.49B 1.46B 63.18B | 2.69B 3.14B 400M 346M 324M 296M 556M 38.1B 565M 3.81B 1.49B 19.08B 1.5B 1.47B 63.62B |
| Net Debt | -12.63B -14.7B -1.87B -1.62B -1.52B -1.39B -2.61B -179B -2.65B -17.88B -6.99B -89.45B -7.03B -6.88B -298B | -14.26B -16.6B -2.12B -1.83B -1.72B -1.57B -2.94B -202B -2.99B -20.19B -7.89B -101B -7.94B -7.77B -337B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 12/08/26 | HK$17.62 | -0.96% | 14,687,498 |
| 11/08/26 | HK$17.79 | -1.17% | 23,915,782 |
| 10/08/26 | HK$18.00 | +0.17% | 29,527,456 |
| 07/08/26 | HK$17.97 | +4.60% | 25,868,872 |
| 06/08/26 | HK$17.18 | -0.23% | 12,092,173 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.

Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- 1530 Stock
Select your edition
All financial news and data tailored to specific country editions
















